Skip to content
MedsAcross

Medicine

Propafenone 225 mg tablet

Propafenone · Oral
Available on requestPrescription onlyUS FDAGeneric name

Propafenone 225 mg tablet is a generic prescription medicine for oral use, made by 6 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20° to 25°C (68° to 77°F),.

Key facts

Active ingredient (INN)
Propafenone
Brand
Sold under the generic name
Strength
225 mg
Dosage form
Tablet
Route
Oral
Packs
300 tablets, 100 tablets, 60 tablets and 9 more
Manufacturers
Strides PharmaIndiaAurobindo PharmaIndiaBryant Ranch PrepackA-S Medication SolutionsANI PharmaceuticalsGolden State Medical Supply
Origin register
US FDA, United States
Storage
Store at 20° to 25°C (68° to 77°F),.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
23 April 2004
Identifiers
RxCUI 861424, 861427, 861430DailyMed set ID 7202aed6-40a9-2bff-e053-2a95a90ae752, a96f9c6f-4c9c-4406-bca8-08bf9a4af1f4, 2492317c-8b04-477e-a5d2-53e791fface9 +6NDC 51407-016, 64380-164, 63629-1988 +6Application ANDA076550, ANDA075938, ANDA202445

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
300 tablet, film coated in 1 bottle, plastic64380-164-01Strides PharmaIndia1 August 2022
100 tablet, film coated in 1 bottle, plastic64380-164-02Strides PharmaIndia1 August 2022
300 tablet, film coated in 1 bottle, plastic64380-268-01Strides PharmaIndia5 May 2025
100 tablet, film coated in 1 bottle, plastic64380-268-02Strides PharmaIndia5 May 2025
100 tablet, film coated in 1 bottle59651-257-01Aurobindo PharmaIndia25 October 2019
300 tablet, film coated in 1 bottle59651-257-33Aurobindo PharmaIndia25 October 2019
100 tablet, coated in 1 bottle62559-231-01ANI Pharmaceuticals31 March 2015
100 tablet, coated in 1 bottle63629-1988-1Bryant Ranch Prepack2 February 2021
100 tablet, coated in 1 bottle72162-1752-1Bryant Ranch Prepack7 February 2024
100 tablet, film coated in 1 bottle72162-2617-1Bryant Ranch Prepack20 April 2026
60 tablet, coated in 1 bottle50090-4227-0A-S Medication Solutions27 March 2019
100 tablet, coated in 1 bottle51407-016-01Golden State Medical Supply11 December 2017

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 27 November 1989Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Propafenone

Clinical summary

Propafenone is an antiarrhythmic indicated to prolong the time to recurrence of symptomatic atrial fibrillation (AF) in patients with episodic (most likely paroxysmal or persistent) AF who do not have structural heart disease, among other approved uses. MedsAcross supplies Propafenone for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Propafenone

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Propafenone 225 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.